by Peter Ueda, Thomas Wai-Chun Lung, Philip Clarke, and Goodarz Danaei

Slides:



Advertisements
Similar presentations
Absolute cardiovascular disease risk Assessment and Early Intervention Dr Michael Tam Lecturer in Primary Care
Advertisements

Figure 1.1 Prevalence of CKD by stage among NHANES participants,
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
Background/Objective
Copyright © 2011 American Medical Association. All rights reserved.
Peak oxygen uptake and prevalence of cardiovascular disease risk factors in breast cancer survivors Lahart1, I.M., Metsios1, G.S., Nevill1, A.M., Kitas1,2,
Chapter 1: CKD in the General Population
Prevalence and control of cardiovascular risk factors using a German sample – Findings from the STAAB Cohort Study Theresa Tiffe1,3, Götz Gelbrich1,2,
Copyright © 2012 American Medical Association. All rights reserved.
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Risks and Assessment NHLBI Obesity Education.
Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN 
Hazard ratio (HR) for mortality for a 1-kg/m2 increase in body mass index (BMI) across the range of baseline BMI among patients with acute ischemic stroke.
Association of low eosinophil and lymphocyte counts with different initial presentations of cardiovascular disease over the first 6 months ‘Low eosinophils’
Neil J. Stone et al. JACC 2014;63:
Heart Disease and Stroke Statistics — 2004 Update
Chronic kidney disease and cause-specific hospitalisation: a matched cohort study using primary and secondary care patient data by Masao Iwagami, Ben Caplin,
Chapter 1: CKD in the General Population
Primary care screening for peripheral arterial disease: a cross-sectional observational study by Jane H Davies, Jonathan Richards, Kevin Conway, Joyce.
by Peter Ueda, Thomas Wai-Chun Lung, Philip Clarke, and Goodarz Danaei
Prospective Studies Collaboration Lancet 2009; 373:
Martin Bødtker Mortensen, and Erling Falk JACC 2018;71:85-94
Missed opportunities in prevention of cardiovascular disease in primary care: a cross-sectional study by James P Sheppard, Kate Fletcher, Richard J McManus,
Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN 
OR (95% CI) for CHD associated with inflammatory markers before and after adjustment for established risk factors. OR (95% CI) for CHD associated with.
Comorbidity and polypharmacy in chronic heart failure: a large cross-sectional study in primary care by Bosco Baron-Franco, Gary McLean, Frances S Mair,
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies  Prospective Studies Collaboration  The.
Incidence of all renal events according to achieved BP levels, adjusted for age, gender, duration of diabetes, glycosylated hemoglobin, currently treated.
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies 
Patient reactions to a web-based cardiovascular risk calculator in type 2 diabetes: a qualitative study in primary care by Tom Nolan, Charlotte Dack, Kingshuk.
Chronic kidney disease and cause-specific hospitalisation: a matched cohort study using primary and secondary care patient data by Masao Iwagami, Ben Caplin,
Quantifying the risk of type 2 diabetes in East London using the QDScore: a cross-sectional analysis by Rohini Mathur, Douglas Noble, Dianna Smith, Trisha.
What is cardiovascular disease?
OR (95% CI) for CHD associated with inflammatory markers in all participants and in subsets of non-users of statins or non-users of aspirin therapy. OR.
Implications of comorbidity for primary care costs in the UK: a retrospective observational study by Samuel L Brilleman, Sarah Purdy, Chris Salisbury,
Doctors record higher blood pressures than nurses: systematic review and meta-analysis by Christopher E Clark, Isabella A Horvath, Rod S Taylor, and John.
Prevalence of systolic inter-arm differences in blood pressure for different primary care populations: systematic review and meta-analysis by Christopher.
by John Robson, Sally Hull, Rohini Mathur, and Kambiz Boomla
Therapeutic decisions by number needed to treat and survival gains: a cross-sectional survey of lipid-lowering drug recommendations by Peder A Halvorsen,
by Nicola Adderley, Ronan Ryan, and Tom Marshall
Body weight reduction to avoid the excess risk of type 2 diabetes
by William Hamilton, Deborah J Sharp, Tim J Peters, and Alison P Round
by Sally Hull, Rohini Mathur, Gavin Dreyer, and Muhammad Magdi Yaqoob
by Samuel Finnikin, Ronan Ryan, and Tom Marshall
Comorbidity and polypharmacy in chronic heart failure: a large cross-sectional study in primary care by Bosco Baron-Franco, Gary McLean, Frances S Mair,
Clinical features of kidney cancer in primary care: a case-control study using primary care records by Elizabeth Shephard, Richard Neal, Peter Rose, Fiona.
Baseline Characteristics of the Subjects*
by Carmen Tsang, Alex Bottle, Azeem Majeed, and Paul Aylin
Impact of primary care funding on secondary care utilisation and patient outcomes: a retrospective cross-sectional study of English general practice by.
Access to general practice and visits to accident and emergency departments in England: cross-sectional analysis of a national patient survey by Thomas.
Impact of primary care funding on secondary care utilisation and patient outcomes: a retrospective cross-sectional study of English general practice by.
The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study by Peter M Brindle, Alex McConnachie, Mark N Upton, Carole.
Trends in the diagnosis and management of hypertension: repeated primary care survey in South West England by Natasha Mejzner, Christopher E Clark, Lindsay.
Volume 64, Issue 2, Pages (August 2003)
Receiver operating curves (ROC) of simple age and gender adjusted risk factor models for predicting 10-year risk of cardiovascular disease comparing the.
Prevalence and costs of treating uncomplicated stage 1 hypertension in primary care: a cross-sectional analysis by James P Sheppard, Kate Fletcher, Richard.
by Kevin Gruffydd-Jones, and Melvyn M Jones
by Peter R Croft, and Elaine Thomas
by Abigail Moore, Anthony Harnden, and Richard Mayon-White
Adjusted HRs (95% CIs) for all-cause mortality associated with body fat percentage by smoking status in men and women and by CHD, type 2 diabetes, and.
Quality-improvement strategies for the management of hypertension in chronic kidney disease in primary care: a systematic review by Hugh Gallagher, Simon.
by Gary Collins, and Douglas Altman
Adjusted prevalence of CHD, atrial fibrillation, and stroke by sex and ethnic group. Numbers for sex are adjusted for age and clustering within practices.
by Rohini Mathur, Sally A Hull, Kambiz Boomla, and John Robson
Determinants of moderate Cardiovascular Health Index Score (CHIS) (achieving three or more risk factor targets). Determinants of moderate Cardiovascular.
by Joanna Broad, Sue Wells, Roger Marshall, and Rod Jackson
ROC curves for LDL cholesterol, apoB, non-HDL cholesterol, and the total cholesterol–to–HDL cholesterol ratio deciles. ROC curves for LDL cholesterol,
Predicted 10-year risk of cardiovascular disease is influenced by the risk equation adopted: a cross-sectional analysis by Benjamin J Gray, Richard M Bracken,
Association Between Hypertension and Kidney Function Decline: The Atherosclerosis Risk in Communities (ARIC) Study  Zhi Yu, Casey M. Rebholz, Eugenia.
The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.
Trends in the epidemiology of smoking recorded in UK general practice
Presentation transcript:

by Peter Ueda, Thomas Wai-Chun Lung, Philip Clarke, and Goodarz Danaei Application of the 2014 NICE cholesterol guidelines in the English population: a cross-sectional analysis by Peter Ueda, Thomas Wai-Chun Lung, Philip Clarke, and Goodarz Danaei BJGP Volume 67(662):e598-e608 August 31, 2017 ©2017 by British Journal of General Practice

The 10-year CVD risk estimated with QRISK2, and by varying levels of single risk factors in hypothetical white males and females at selected ages.a aOther risk factors in the risk prediction equation were either held constant at median levels in HSE 2011 (B... The 10-year CVD risk estimated with QRISK2, and by varying levels of single risk factors in hypothetical white males and females at selected ages.aaOther risk factors in the risk prediction equation were either held constant at median levels in HSE 2011 (BMI, systolic BP, total-to-HDL cholesterol ratio) or assumed to be non-existent (type 1 and 2 diabetes, smoking, treated hypertension, family history of coronary heart disease in first-degree relative <60 years, chronic kidney disease, atrial fibrillation, rheumatoid arthritis, and Townsend score). BMI = body mass index. CVD = cardiovascular disease. HDL = high-density lipoprotein. HSE = Health Survey for England. Peter Ueda et al. Br J Gen Pract 2017;67:e598-e608 ©2017 by British Journal of General Practice

The 10-year CVD risk estimated with QRISK2, by age for hypothetical white males and females with different combinations of risk factors as shown in Table 1.a,b aOptimal/high BMI = 22.5/30.1 kg/m2. The 10-year CVD risk estimated with QRISK2, by age for hypothetical white males and females with different combinations of risk factors as shown in Table 1.a,baOptimal/high BMI = 22.5/30.1 kg/m2. Optimal/high total-to-HDL cholesterol ratio = 4.0/5.2. Optimal systolic BP = 110 mmHg (untreated). Treated systolic BP = 135 mmHg. Optimal smoking status = never smoker. bAll other risk factors were assumed to be non-existent (type 1 diabetes, family history of coronary heart disease in first-degree relative <60 years, chronic kidney disease, atrial fibrillation, rheumatoid arthritis, and Townsend score). BMI = body mass index. CVD = cardiovascular disease. HDL = high-density lipoprotein. Peter Ueda et al. Br J Gen Pract 2017;67:e598-e608 ©2017 by British Journal of General Practice

The 10-year CVD risk estimated with QRISK2, by age and ethnicity, for hypothetical males and females with optimal risk factor levels.a aBMI = 22.5 kg/m2. The 10-year CVD risk estimated with QRISK2, by age and ethnicity, for hypothetical males and females with optimal risk factor levels.aaBMI = 22.5 kg/m2. Systolic BP = 110 mmHg. Total-to-HDL cholesterol ratio = 4, and never smoker and no diabetes. All other risk factors were assumed to be non-existent (family history of coronary heart disease in first-degree relative <60 years, chronic kidney disease, atrial fibrillation, rheumatoid arthritis, and Townsend score). CVD = cardiovascular disease. Peter Ueda et al. Br J Gen Pract 2017;67:e598-e608 ©2017 by British Journal of General Practice

Proportion of the adult English population without existing CVD who are receiving statin therapy, or are eligible but not receiving statins, under the 2014 NICE guidelines, by age and sex. Proportion of the adult English population without existing CVD who are receiving statin therapy, or are eligible but not receiving statins, under the 2014 NICE guidelines, by age and sex. CVD = cardiovascular disease. NICE = National Institute for Health and Care Excellence. Peter Ueda et al. Br J Gen Pract 2017;67:e598-e608 ©2017 by British Journal of General Practice